ITP Trials

Argenx ARGX-113-2004

A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and theSafety of Efgartigimod (ARGX-113) PH20 Subcutaneous in
Adult Patients With Primary Immune Thrombocytopenia

Fort Wayne North Office
(260) 484-8830
2514 E Dupont Road, Suite 100
Fort Wayne, IN 46825

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.

Privacy Policy | Sitemap